DNTH: Dianthus Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Dianthus Therapeutics Inc (DNTH).

OverviewDividends

$645.21M Market Cap.

As of 05/13/2025 5:00 PM ET (MRY) • Disclaimer

DNTH Market Cap. (MRY)


DNTH Shares Outstanding (MRY)


DNTH Assets (MRY)


Total Assets

$374.01M

Total Liabilities

$21.53M

Total Investments

$334.18M

DNTH Income (MRY)


Revenue

$6.24M

Net Income

-$84.97M

Operating Expense

$108.10M

DNTH Cash Flow (MRY)


CF Operations

-$78.18M

CF Investing

-$286.81M

CF Financing

$255.62M

DNTH Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$374,008,000 (108.47%)

$179,405,000 (115.86%)

$83,110,000 (-56.24%)

$189,934,000 (17.52%)

Assets Current

$280,904,000 (58.30%)

$177,451,000 (116.32%)

$82,033,000 (-54.60%)

$180,693,000 (19.25%)

Assets Non-Current

$93,104,000 (4664.79%)

$1,954,000 (81.43%)

$1,077,000 (-88.35%)

$9,241,000 (-8.43%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$352,477,000 (108.73%)

$168,870,000 (480.61%)

-$44,368,000 (-125.69%)

$172,672,000 (19.99%)

Property Plant & Equipment Net

$1,747,000 (118.38%)

$800,000 (-16.32%)

$956,000 (-87.19%)

$7,461,000 (-10.24%)

Cash & Equivalents

$22,792,000 (-82.78%)

$132,325,000 (761.21%)

$15,365,000 (-88.48%)

$133,430,000 (122.64%)

Accumulated Other Comprehensive Income

$106,000 (125.53%)

$47,000 (129.19%)

-$161,000 (-436.67%)

-$30,000 (-30.43%)

Deferred Revenue

$2,387,000 (185.53%)

$836,000 (-6.17%)

$891,000 (0%)

$0 (0%)

Total Investments

$334,177,000 (707.33%)

$41,393,000 (-31.16%)

$60,125,000 (32.80%)

$45,276,000 (-50.07%)

Investments Current

$252,449,000 (509.88%)

$41,393,000 (-31.16%)

$60,125,000 (32.80%)

$45,276,000 (-50.07%)

Investments Non-Current

$81,728,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$807,000 (68.83%)

$478,000 (-91.52%)

$5,638,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,579,000 (75.44%)

$2,610,000 (123.65%)

$1,167,000 (-61.61%)

$3,040,000 (-19.15%)

Accumulated Retained Earnings (Deficit)

-$174,392,000 (-95.02%)

-$89,423,000 (-94.96%)

-$45,868,000 (85.91%)

-$325,567,000 (-27.96%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,491,000 (154.87%)

$585,000 (-25.76%)

$788,000 (0%)

$0 (0%)

Debt Current

$320,000 (-23.26%)

$417,000 (19.14%)

$350,000 (0%)

$0 (0%)

Debt Non-Current

$1,171,000 (597.02%)

$168,000 (-61.64%)

$438,000 (0%)

$0 (0%)

Total Liabilities

$21,531,000 (104.38%)

$10,535,000 (11.43%)

$9,454,000 (-45.23%)

$17,262,000 (-2.55%)

Liabilities Current

$18,452,000 (91.59%)

$9,631,000 (17.09%)

$8,225,000 (-24.28%)

$10,863,000 (-4.96%)

Liabilities Non-Current

$3,079,000 (240.60%)

$904,000 (-26.44%)

$1,229,000 (-80.79%)

$6,399,000 (1.85%)

DNTH Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$6,235,000 (120.63%)

$2,826,000 (-55.96%)

$6,417,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$24,994,000 (37.64%)

$18,159,000 (169.30%)

$6,743,000 (-75.85%)

$27,926,000 (-0.57%)

Research & Development Expense

$83,105,000 (153.05%)

$32,841,000 (11.78%)

$29,379,000 (-37.18%)

$46,766,000 (-7.60%)

Operating Expenses

$108,099,000 (111.96%)

$51,000,000 (41.19%)

$36,122,000 (-51.64%)

$74,692,000 (-5.10%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$84,969,000 (-95.08%)

-$43,555,000 (-52.95%)

-$28,476,000 (59.97%)

-$71,136,000 (5.07%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$84,969,000 (-95.08%)

-$43,555,000 (-52.95%)

-$28,476,000 (59.97%)

-$71,136,000 (5.07%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$84,969,000 (-95.08%)

-$43,555,000 (-52.95%)

-$28,476,000 (59.97%)

-$71,136,000 (5.07%)

Weighted Average Shares

$33,313,849 (546.44%)

$5,153,423 (489.48%)

$874,234 (-74.54%)

$3,434,300 (25.11%)

Weighted Average Shares Diluted

$33,313,849 (546.44%)

$5,153,423 (489.48%)

$874,234 (-74.54%)

$3,434,300 (25.11%)

Earning Before Interest & Taxes (EBIT)

-$84,969,000 (-95.08%)

-$43,555,000 (-52.95%)

-$28,476,000 (59.97%)

-$71,136,000 (5.07%)

Gross Profit

$6,235,000 (120.63%)

$2,826,000 (-55.96%)

$6,417,000 (0%)

$0 (0%)

Operating Income

-$101,864,000 (-111.45%)

-$48,174,000 (-62.17%)

-$29,705,000 (60.23%)

-$74,692,000 (5.10%)

DNTH Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$286,812,000 (-1516.15%)

$20,253,000 (133.86%)

-$59,819,000 (-237.74%)

$43,428,000 (508.35%)

Net Cash Flow from Financing

$255,623,000 (91.37%)

$133,574,000 (38.17%)

$96,676,000 (7.90%)

$89,601,000 (32.27%)

Net Cash Flow from Operations

-$78,180,000 (-112.09%)

-$36,861,000 (-26.80%)

-$29,070,000 (51.17%)

-$59,531,000 (7.02%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$109,369,000 (-193.50%)

$116,966,000 (1402.07%)

$7,787,000 (-89.41%)

$73,498,000 (1162.26%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$286,707,000 (-1507.98%)

$20,363,000 (134.12%)

-$59,680,000 (-233.54%)

$44,692,000 (536.66%)

Capital Expenditure

-$105,000 (4.55%)

-$110,000 (20.86%)

-$139,000 (89.00%)

-$1,264,000 (-216.00%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$270,288,000 (5405660.00%)

$5,000 (0%)

$0 (0%)

$89,904,000 (32.14%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$12,894,000 (344.62%)

$2,900,000 (91.04%)

$1,518,000 (-85.27%)

$10,308,000 (3.69%)

Depreciation Amortization & Accretion

$412,000 (16.06%)

$355,000 (141.50%)

$147,000 (-92.72%)

$2,020,000 (2.12%)

DNTH Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00%

-

Profit Margin

-1362.80% (11.58%)

-1541.20% (-247.27%)

-443.80%

-

EBITDA Margin

-1356.20% (11.28%)

-1528.70% (-246.25%)

-441.50%

-

Return on Average Equity (ROAE)

-23.90% (31.52%)

-34.90% (-12.22%)

-31.10% (24.15%)

-41.00% (17.67%)

Return on Average Assets (ROAA)

-23.00% (29.45%)

-32.60% (-76.22%)

-18.50% (50.53%)

-37.40% (16.14%)

Return on Sales (ROS)

-1362.80% (11.58%)

-1541.20% (-247.27%)

-443.80%

-

Return on Invested Capital (ROIC)

-46.60% (73.26%)

-174.30% (-602.82%)

-24.80% (80.89%)

-129.80% (9.55%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-8.55 (-594.48%)

-1.23 (-534.54%)

-0.19 (94.35%)

-3.43 (25.10%)

Price to Sales Ratio (P/S)

116.48 (514.17%)

18.96 (2102.67%)

0.86

-

Price to Book Ratio (P/B)

1.83 (100.55%)

0.91 (269.39%)

-0.54 (-135.74%)

1.51 (-42.71%)

Debt to Equity Ratio (D/E)

0.06 (-1.61%)

0.06 (129.11%)

-0.21 (-313.00%)

0.1 (-18.70%)

Earnings Per Share (EPS)

-2.55 (69.82%)

-8.45 (74.06%)

-32.57 (-57.80%)

-20.64 (24.56%)

Sales Per Share (SPS)

0.19 (-65.88%)

0.55 (-92.53%)

7.34 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.35 (67.24%)

-7.17 (78.53%)

-33.41 (-88.74%)

-17.7 (24.57%)

Book Value Per Share (BVPS)

10.58 (-67.71%)

32.77 (164.57%)

-50.75 (-200.94%)

50.28 (-4.09%)

Tangible Assets Book Value Per Share (TABVPS)

11.23 (-67.75%)

34.81 (-63.38%)

95.07 (71.89%)

55.3 (-6.07%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (0%)

0 (0%)

0 (0%)

-1 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-7.24 (-12575.86%)

0.06 (-73.02%)

0.21 (114.71%)

-1.46 (54.65%)

Asset Turnover

0.02 (-19.05%)

0.02 (-50.00%)

0.04 (0%)

0 (0%)

Current Ratio

15.22 (-17.38%)

18.43 (84.73%)

9.97 (-40.04%)

16.63 (25.47%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$78,285,000 (-111.75%)

-$36,971,000 (-26.57%)

-$29,209,000 (51.95%)

-$60,795,000 (5.63%)

Enterprise Value (EV)

$611,853,837 (24503.14%)

-$2,507,275 (58.83%)

-$6,090,570 (-106.03%)

$101,064,311 (-57.04%)

Earnings Before Tax (EBT)

-$84,969,000 (-95.08%)

-$43,555,000 (-52.95%)

-$28,476,000 (59.97%)

-$71,136,000 (5.07%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$84,557,000 (-95.73%)

-$43,200,000 (-52.49%)

-$28,329,000 (59.01%)

-$69,116,000 (5.27%)

Invested Capital

$334,255,000 (778.83%)

$38,034,000 (-36.93%)

$60,308,000 (32.14%)

$45,641,000 (-49.43%)

Working Capital

$262,452,000 (56.39%)

$167,820,000 (127.37%)

$73,808,000 (-56.54%)

$169,830,000 (21.22%)

Tangible Asset Value

$374,008,000 (108.47%)

$179,405,000 (115.86%)

$83,110,000 (-56.24%)

$189,934,000 (17.52%)

Market Capitalization

$645,213,837 (318.69%)

$154,104,725 (544.27%)

$23,919,430 (-90.81%)

$260,383,311 (-31.24%)

Average Equity

$355,320,000 (184.65%)

$124,828,500 (36.23%)

$91,630,750 (-47.21%)

$173,577,750 (15.37%)

Average Assets

$369,919,250 (177.12%)

$133,486,500 (-13.42%)

$154,184,750 (-18.97%)

$190,292,000 (13.37%)

Invested Capital Average

$182,219,250 (629.37%)

$24,983,000 (-78.25%)

$114,865,000 (109.57%)

$54,809,250 (4.95%)

Shares

29,596,965 (99.74%)

14,817,762 (291.52%)

3,784,720 (3.03%)

3,673,579 (21.68%)